Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. (2018)

First Author: Sliz E

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.36320

Publication URI: https://www.repository.cam.ac.uk/handle/1810/289058

Type: Journal Article/Review